Geertrui Vanhove

Director, Insys Therapeutics, Inc.

Companies

Surrozen, Inc./DEChief Medical Officer Aug 16, 2021 to Dec 19, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Surrozen, Inc./DE SRZN32,412 shares²$805.4K at $24.85Dec 15, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 15, 2022Granted 9,578 shares at $0.41 of Surrozen, Inc./DE²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSurrozen, Inc./DE, Chief Medical Officer
2
SEC EDGARSurrozen, Inc./DE shares after the filing of Dec 15, 2022